World News1 min read

Jyothy Labs has cash to buy growth. Why it isn’t rushing

With ₹997 crore in cash and no debt, Jyothy Labs could use acquisitions to rebuild its portfolio after Henkel ended its Pril and Fa licensing deal. Instead, it is betting on new products and existing brands.

T

The News Flicker

Jyothy Labs has cash to buy growth. Why it isn’t rushing

With ₹997 crore in cash and no debt, Jyothy Labs could use acquisitions to rebuild its portfolio after Henkel ended its Pril and Fa licensing deal. Instead, it is betting on new products and existing brands.

I don't want to rush into something that could create a problem for us for years to come, Jyothy said. That approach contrasts with the broader consumer-goods sector, where peers have continued to a…

Originally published by Livemint. Read the full article →

More from World News